Covid-19 roundup: FDA gives OK to use ex­tra dos­es in Pfiz­er/BioN­Tech vac­cine vials; Sinophar­m's Pe­ru tri­al to re­sume

While Pfiz­er and the US gov­ern­ment are still ne­go­ti­at­ing for more dos­es of its BioN­Tech-part­nered mR­NA vac­cine, the FDA has cleared the way for phar­ma­cists to squeeze more dos­es out of the cur­rent sup­ply.

Phar­ma­cists dis­cov­ered the ex­tra dos­es soon af­ter the vac­ci­na­tion cam­paign be­gan on Tues­day fol­low­ing an emer­gency use au­tho­riza­tion over the week­end. While the EUA la­bel states that each vial con­tains 5 dos­es of the vac­cine — each com­ing at 0.3 mL and re­quir­ing di­lu­tion — they re­al­ized that there’s of­ten enough left for an­oth­er full dose, or even two.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER